TNF 308 G/A polymorphism and type 1 diabetes: A meta-analysis

Diabetes Research and Clinical Practice

Volumn 85, Issue 1, 2009, Pages

  Feng, Ren Nan ^a   Li, Ying ^a   Sun, Chang Hao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Genetics; Meta analysis; Polymorphism; TNF

Indexed keywords

ADENINE; GUANINE; TUMOR NECROSIS FACTOR;

ARTICLE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; RISK FACTOR;

ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; HUMANS; META-ANALYSIS AS TOPIC; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349238234     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.04.026     Document Type: Article

References (20)

1. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
2. Dahlen E., Dawe K., Ohlsson L., and Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J. Immunol. 160 (1998) 3585-3593
3. Pociot F., Wilson A.G., Nerup J., and Duff G.W. No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur. J. Immunol. 23 (1993) 3050-3053
4. Wu X., Zhang W.J., Witt C.S., Abraham L.J., Christiansen F.T., and Dawkins R.L. Haplospecific polymorphism between HLA B and tumor necrosis factor. Hum. Immunol. 33 (1992) 89-97
5. Boraska V., Skrabic V., Culic V.C., Becic K., Kapitanovic S., and Zemunik T. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population. Biol. Res. 41 (2008) 157-163
6. Bouqbis L., Akhayat O., Garchon H.J., Calafell F., and Izaabel H. TNFA-TNFB haplotypes modify susceptibility to type I diabetes mellitus independently of HLA class II in a Moroccan population. Tissue Antigens 61 (2003) 72-79
7. Das S.N., Baniasadi V., and Kapuria V. Association of -308 TNF-alpha promoter polymorphism with type 1 diabetes in North Indians. Int. J. Immunogenet. 33 (2006) 411-416
8. Deja G., Jarosz-Chobot P., Polanska J., Siekiera U., and Malecka-Tendera E. Is the association between TNF-alpha-308 A allele and DMT1 independent of HLA-DRB1, DQB1 alleles?. Mediators Inflamm. 2006 (2006) 19724
9. Deng G.Y., Maclaren N.K., Huang H.S., Zhang L.P., and She J.X. No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. Hum. Immunol. 45 (1996) 137-142
10. Kumar R., Goswami R., Agarwal S., Israni N., Singh S.K., and Rani R. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens 69 (2007) 557-567
11. Li H., Groop L., Nilsson A., Weng J., and Tuomi T. A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 88 (2003) 2767-2774
12. Lindholm E., Bakhtadze E., Cilio C., Agardh E., Groop L., and Agardh C.D. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS ONE 3 (2008) e2546
13. Perez C., Gonzalez F.E., Pavez V., Araya A.V., Aguirre A., Cruzat A., et al. The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus. Eur. Cytokine Netw. 15 (2004) 364-370
14. Stayoussef M., Al-Jenaidi F.A., Al-Abbasi A., Al-Ola K., Khayyat H., Mahjoub T., et al. Modulation of type 1 diabetes susceptibility by tumor necrosis factor alpha -308 G/A and lymphotoxin alpha +249 A/G haplotypes and lack of linkage disequilibrium with predisposing DQB1-DRB1 haplotypes in Bahraini patients. Clin. Vac. Immunol. 15 (2008) 379-381
15. Vatay A., Rajczy K., Pozsonyi E., Hosszufalusi N., Prohaszka Z., Fust G., et al. Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunol. Lett. 84 (2002) 109-115
16. Nishimura M., Obayashi H., Mizuta I., Hara H., Adachi T., Ohta M., et al. TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum. Immunol. 64 (2003) 302-309
17. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3195-3199
18. Noble J.A., Valdes A.M., Lane J.A., Green A.E., and Erlich H.A. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility. Hum. Immunol. 67 (2006) 999-1004
19. Bendtzen K., Morling N., Fomsgaard A., Svenson M., Jakobsen B., Odum N., et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 28 (1988) 599-606
20. Pociot F., Briant L., Jongeneel C.V., Molvig J., Worsaae H., Abbal M., et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23 (1993) 224-231